Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES StudyBernard Escudier, Camillo Porta, Petri Bono, et al.
Medicine and Science in Sports and Exercise|July 26, 2022
Supervised Physical Activity Quickly Improves Social Dimension of Quality of Life in Breast Cancer PatientsAnaïs Briant, Charline Frandemiche, Emmanuel Sevin, et al.
Journal of Medicinal Chemistry|April 18, 2017
Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose ToleranceManuel Lasalle, Vanessa Hoguet, Nathalie Hennuyer, et al.
BJU International|November 5, 2013
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 studyFlorence Joly, Remy Delva, Loïc Mourey, et al.
International Journal of Pharmaceutics|July 15, 2026
Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategiesLine Séguy, Léna Guyon, Sophie Corvaisier, et al.
Journal of Medicinal Chemistry|January 20, 2021
Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure-Properties Relationships of mPEGylated Small Agonists of TGR5 ReceptorVanessa Hoguet, Manuel Lasalle, Mathieu Maingot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2015
How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI studyJulie Vanbockstael, Elodie Coquan, Sophie Gouerant, et al.
Journal of Medicinal Chemistry|August 28, 2023
Discovery, Structure-Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5Sylvain Picon, Rajaa Boulahjar, Vanessa Hoguet, et al.
JAMA Oncology|October 26, 2023
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical TrialStéphane Oudard, Raffaele Ratta, Eric Voog, et al.
JAMA Oncology|February 1, 2019
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical TrialStéphane Oudard, Igor Latorzeff, Armelle Caty, et al.
Pageof 6